Diagnostic Medical Systems (XPAR:ALDMS) LT-Debt-to-Total-Asset: 0.16 (As of Dec. 2025)

What is Diagnostic Medical Systems LT-Debt-to-Total-Asset?

Diagnostic Medical Systems XPAR:ALDMS +2.90% 66 LT-Debt-to-Total-Asset is 0.16 as of Dec. 2025. GuruFocus rates XPAR:ALDMS with a GF Score™ of 66/100 and a GF Value™ of €1.14 (Fairly Valued). The stock has 4 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Diagnostic Medical Systems's long-term debt to total assests ratio for the quarter that ended in Dec. 2025 was 0.16.

Diagnostic Medical Systems's long-term debt to total assets ratio declined from Jun. 2024 (0.25) to Dec. 2025 (0.16). It may suggest that Diagnostic Medical Systems is progressively becoming less dependent on debt to grow their business.

Diagnostic Medical Systems (XPAR:ALDMS) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Diagnostic Medical Systems LT-Debt-to-Total-Asset Related Terms

Diagnostic Medical Systems LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Diagnostic Medical Systems's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diagnostic Medical Systems LT-Debt-to-Total-Asset Chart

Diagnostic Medical Systems Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.19

0.26

0.21

0.16

Diagnostic Medical Systems Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Dec25
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.20	0.26	0.25	0.21	0.16

66GF Score

Diagnostic Medical Systems XPAR:ALDMS

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Diagnostic Medical Systems LT-Debt-to-Total-Asset Calculation

Diagnostic Medical Systems's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )	/	Total Assets (A: Dec. 2025 )
	=	9.781	/	62.517
	=	0.16

Diagnostic Medical Systems's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (Q: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2025 )	/	Total Assets (Q: Dec. 2025 )
	=	9.781	/	62.517
	=

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.16 mean?

Diagnostic Medical Systems (XPAR:ALDMS) has a LT-Debt-to-Total-Asset of 0.16 as of Dec. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Diagnostic Medical Systems and its competitors.

Is Diagnostic Medical Systems' LT-Debt-to-Total-Asset too high?

Diagnostic Medical Systems' current LT-Debt-to-Total-Asset is 0.16. Overall, Diagnostic Medical Systems has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Diagnostic Medical Systems' LT-Debt-to-Total-Asset compare to ABT and SYK?

Diagnostic Medical Systems' LT-Debt-to-Total-Asset of 0.16 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?

A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Diagnostic Medical Systems and its competitors. Diagnostic Medical Systems's current LT-Debt-to-Total-Asset is 0.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Diagnostic Medical Systems stock overvalued right now?

Based on GuruFocus' analysis, Diagnostic Medical Systems (XPAR:ALDMS) is currently considered Fairly Valued. The stock's GF Value™ is €1.14, compared to a current price of €1.24 — trading 8.8% above its estimated fair value. The current LT-Debt-to-Total-Asset is 0.16. Diagnostic Medical Systems' overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Diagnostic Medical Systems (XPAR:ALDMS), the current LT-Debt-to-Total-Asset is 0.16 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Diagnostic Medical Systems (XPAR:ALDMS) Overvalued in 2026?

Based on GuruFocus' analysis, Diagnostic Medical Systems stock appears to be overvalued. The current stock price of €1.24 is trading 8.8% above its estimated GF Value™ of €1.14. GuruFocus considers Diagnostic Medical Systems to be Fairly Valued.

Key valuation signals for XPAR:ALDMS:

LT-Debt-to-Total-Asset: 0.16
GF Value™: €1.14 vs. price of €1.24 (8.8% above fair value)
GF Score™: 66/100 with 4 warning signs

No single metric tells the full story. See the XPAR:ALDMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Diagnostic Medical Systems Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies XPAR:ALMKT XPAR:ALNOV XPAR:ALIMP XPAR:ALIKO XPAR:ALTHE XPAR:ALBIO XPAR:ALSGD XPAR:ALBLU XPAR:GBT ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760 STE

Other Exchanges 0RIA:UK DMS1:Germany

Address 9 Avenue du Canal Philippe, Gallargues le Montueux, FRA, FR-30660

Website https://www.dms.com

Diagnostic Medical Systems is France's company engaged in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: Radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; and the Development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine.

66GF Score

Get the complete analysis for XPAR:ALDMS

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.24

Price

€1.14

GF Value

View XPAR:ALDMS Analysis

See LT-Debt-to-Total-Asset data for all stocks →